This site uses cookies to bring you the best experience. Find out more
Skip to main content

SECURITIES INFORMATION

 

NUMBER OF AIM SECURITIES IN ISSUE

As of 24 March 2020, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS

As of 24 March 2020, significant shareholdings in the share capital of Eden Research plc were:
 

Name

Number of shares

% of the issued ordinary share capital

BGF Investment Management Limited
 

58,333,000

15.34%

Sipcam Oxon S.p.A.
 

37,614,830

9.89%

Gresham House Asset Management Limited
 

27,845,445

7.32%

Canaccord Genuity Group Inc
 

22,684,000

5.96%

Amati AIM VCT plc
 

16,937,750

4.45%

Rathbone Nominees Limited
 

16,670,800

4.38%

HSBC Global Custody Nominee (UK) Limited
 

14,015,588

3.69%

JM Finn Nominees Limited
 

13,939,430

3.66%

DIRECTORS' SHAREHOLDINGS

Director

Number of shares

% of the issued ordinary share capital

A Abrey                                                                  
 

1,302,824

0.34%

L van der Broek
 

929,500

0.24%

S Smith
 

731,039

0.19%

R Cridland
 

130,167

0.03%

SHARES NOT IN PUBLIC HANDS

In the terms of AIM Rules published July 2016 and insofar as it is aware, at 24 March 2020, 33.36% of the Company's AIM securities was not in public hands.

RESTRICTION IN TRANSFER OF AIM SECURITIES

There are no restrictions on the transfer of Eden Research Plc's AIM securities.

DETAILS OF ANY OTHER EXCHANGES AND TRADING PLATFORMS

Eden Research Plc has not applied or agreed to have any of it securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.

UK CITY CODE ON TAKEOVERS AND MERGERS

As an AIM traded UK registered company, Eden Research plc is subject to the UK City Code on Takeovers and Mergers legislation.